1. Association of gene and protein expression and genetic polymorphism of CC chemokine ligand 4 in colorectal cancer
    Levar Shamoun et al, 2021, WJG CrossRef
  2. null
    Catuxa Celeiro Muñoz et al, 2022 CrossRef
  3. The preventive and therapeutic potential of native Brazilian fruits on colorectal cancer
    Roberto de Paula do Nascimento et al, 2022, Food Bioscience CrossRef
  4. Organoid: Next-Generation Modeling of Cancer Research and Drug Development
    Jungang Liu et al, 2022, Front. Oncol. CrossRef
  5. Contribution of Epithelial and Gut Microbiome Inflammatory Biomarkers to the Improvement of Colorectal Cancer Patients’ Stratification
    Elena Ionica et al, 2022, Front. Oncol. CrossRef
  6. Uniparental disomy is a chromosomic disorder in the first place
    Thomas Liehr, 2022, Mol Cytogenet CrossRef
  7. Molecular Network of Colorectal Cancer and Current Therapeutic Options
    Zhe Huang et al, 2022, Front. Oncol. CrossRef
  8. Effects of diabetes type 2 and metformin treatment in Swedish patients with colorectal cancer
    Jan Dimberg et al, 2022, WJG CrossRef
  9. Colorectal cancer: risk factors and potential of dietary probiotics in its prevention
    Rajni Arora et al, 2022, Proc.Indian Natl. Sci. Acad. CrossRef
  10. Association of β-Catenin, APC, SMAD3/4, Tp53, and Cyclin D1 Genes in Colorectal Cancer: A Systematic Review and Meta-Analysis
    Hongfeng Yan et al, 2022, Genetics Research CrossRef
  11. Regulation of transforming growth factor-β signaling as a therapeutic approach to treating colorectal cancer
    Jana Maslankova et al, 2022, WJG CrossRef
  12. Polymeric Nanoparticles—Tools in a Drug Delivery System in Selected Cancer Therapies
    Marcel Madej et al, 2022, Applied Sciences CrossRef
  13. Short Linear Motifs in Colorectal Cancer Interactome and Tumorigenesis
    Candida Fasano et al, 2022, Cells CrossRef
  14. Exploring the effect of silver nanoparticles on gene expression in colon cancer cell line HCT116
    Hussah M. Alobaid et al, 2022 CrossRef
  15. Inhibition of colorectal cancer tumorigenesis by ursolic acid and doxorubicin is mediated by targeting the Akt signaling pathway and activating the Hippo signaling pathway.
    Dan Hu et al, 2023, Mol Med Rep CrossRef
  16. Cross-talk between AMP-activated protein kinase and the sonic hedgehog pathway in the high-fat diet triggered colorectal cancer
    T.B. Beena et al, 2023, Archives of Biochemistry and Biophysics CrossRef
  17. Autophagy and the Insulin-like Growth Factor (IGF) System in Colonic Cells: Implications for Colorectal Neoplasia
    Aldona Kasprzak, 2023, IJMS CrossRef
  18. The Rise of Gastrointestinal Cancers as a Global Phenomenon: Unhealthy Behavior or Progress?
    Silvia Rodrigues Jardim et al, 2023, IJERPH CrossRef
  19. Phloretin induces G2/M arrest and apoptosis by suppressing the β-catenin signaling pathway in colorectal carcinoma cells
    Smita Kapoor et al, 2023, Apoptosis CrossRef
  20. UBXN2A suppresses the Rictor-mTORC2 signaling pathway, an established tumorigenic pathway in human colorectal cancer
    Sanam Sane et al, 2023, Oncogene CrossRef
  21. Principles of Molecular Utility for CMS Classification in Colorectal Cancer Management
    Leili Rejali et al, 2023, Cancers CrossRef
  22. Clinicopathological Features of Colorectal Cancer in the Iraqi Population Focusing on Age and Early-Onset of Malignancy: A Descriptive Cross-Sectional Study
    Rand Mutanna Farhad et al, 2023, Al-Rafidain J Med Sci CrossRef
  23. RIZ2 at the crossroad of the EGF/EGFR signaling in colorectal cancer
    Marzia Di Donato et al, 2023, J Transl Med CrossRef
  24. CLDN6 inhibits colorectal cancer proliferation dependent on restraining p53 ubiquitination via ZO-1/PTEN axis
    Yuan Dong et al, 2023, Cellular Signalling CrossRef
  25. Activation of AKT induces EZH2-mediated β-catenin trimethylation in colorectal cancer
    Ahmed H. Ghobashi et al, 2023, iScience CrossRef
  26. Development and validation of a nomogram predictive model for colorectal adenoma with low-grade intraepithelial neoplasia using routine laboratory tests: A single-center case-control study in China
    Huaguang Wang et al, 2023, Heliyon CrossRef
  27. Repurposing Synthetic Congeners of a Natural Product Aurone Unveils a Lead Antitumor Agent Inhibiting Folded P-Loop Conformation of MET Receptor Tyrosine Kinase
    Ahmed H. E. Hassan et al, 2023, Pharmaceuticals CrossRef
  28. LncRNA MEG3 inhibits the proliferation and migration abilities of colorectal cancer cells by competitively suppressing MiR-31 and reducing the binding of MiR-31 to target gene SFRP1
    Zheli Li et al, 2023, Aging CrossRef
  29. FOXM1 and MMR genes immunohistochemical expression in colorectal cancer: promising prognostic insights and candidate therapeutic targets
    Lobna S Shash et al, 2023, EGJP CrossRef
  30. Effect of Quercetin on Fecal Syndecan-2 Gene Methylation Levels in Patients with Colorectal Cancer and Its Potential Mechanism of Action
    Nanyang Li et al, 2023, sci adv mater CrossRef
  31. A perspective on emerging therapies in metastatic colorectal cancer: Focusing on molecular medicine and drug resistance.
    Anggraeni E Kusumaningrum et al, 2024, Cell Biochem Funct CrossRef
  32. Curcumin affects apoptosis of colorectal cancer cells through ATF6‐mediated endoplasmic reticulum stress
    Wei Xu et al, 2024, Chem Biol Drug Des CrossRef
  33. Navigating Molecular Pathways: An Update on Drugs in Colorectal Cancer Treatment
    Neha Shree Maurya et al, 2023, CTMC CrossRef
  34. null
    Afza Ahmad et al, 2024 CrossRef
  35. null
    Prafulla Sabale et al, 2024 CrossRef
  36. Signet ring-cell colorectal adenocarcinoma: review and clinical case
    S. S. Yashin et al, 2024, Medicinskij sovet CrossRef
  37. KLF15 transcriptionally activates LINC00689 to inhibit colorectal cancer development
    Yan Cao et al, 2024, Commun Biol CrossRef
  38. Regulation of the migration of colorectal cancer stem cells via the TLR4/MyD88 signaling pathway by the novel surface marker CD14 following LPS stimulation
    Yufei Li et al, 2023, Oncol Lett CrossRef
  39. Development and validation of a prediction model for early screening of people at high risk for colorectal cancer
    Ling-Li Xu et al, 2024, World J Gastroenterol CrossRef
  40. TSC22D2 Regulates ACOT8 to Delay the Malignant Progression of Colorectal Cancer
    Nana Zhou et al, 2024, OTT CrossRef
  41. mRNA expression profiling of leptin and adiponectin and its receptors in colorectal carcinoma – Biomarker development
    Priyanka Parmesh et al, 2024, Advances in Cancer Biology - Metastasis CrossRef
  42. ENO1 deletion potentiates ferroptosis and decreases glycolysis in colorectal cancer cells via AKT/STAT3 signaling
    Ying Liu et al, 2024, Exp Ther Med CrossRef
  43. Identification of EDNRA as the Key Biomarker for Hypercholesterolemia and Colorectal Cancer
    Kedong Han et al, 2024, Tohoku J. Exp. Med. CrossRef
  44. The Natural Product Secoemestrin C Inhibits Colorectal Cancer Stem Cells via p38–S100A8 Feed-Forward Regulatory Loop
    Huimin Zhou et al, 2024, Cells CrossRef
  45. Human β-defensin-1 affects the mammalian target of rapamycin pathway and autophagy in colon cancer cells through long non-coding RNA TCONS_00014506
    Yu-Xin Zhao et al, 2024, World J Gastrointest Oncol CrossRef
  46. Exploring the integration of nanotechnology in the development and application of biosensors for enhanced detection and monitoring of colorectal cancer
    Ashkan Hajjafari et al, 2024, Inorganic Chemistry Communications CrossRef
  47. A prognostic model established using bile acid genes to predict the immunity and survival of patients with gastrointestinal cancer
    Xin Wu et al, 2024, Environmental Toxicology CrossRef
  48. Exploring the Key Signaling Pathways and ncRNAs in Colorectal Cancer
    Yun Ju Lee et al, 2024, IJMS CrossRef
  49. Spheroids and organoids derived from colorectal cancer as tools for in vitro drug screening
    Sahira Syamimi Ahmad Zawawi et al, 2024 CrossRef
  50. Interferon-induced transmembrane protein 2 is a prognostic marker in colorectal cancer and promotes its progression by activating the PI3K/AKT pathway
    Yonggang Liu et al, 2024, Discov Onc CrossRef
  51. Laser-activable murine ferritin nanocage for chemo-photothermal therapy of colorectal cancer
    Jinmei Cheng et al, 2024, J Nanobiotechnol CrossRef
  52. Novel meroterpene-like compounds inhibit ferroptosis through Fe2+ chelation
    Shiyang Lou et al, 2024, The International Journal of Biochemistry & Cell Biology CrossRef
  53. Loss of monopolar spindle-binding protein 3B expression promotes colorectal cancer malignant behaviors by activation of target of rapamycin kinase/autophagy signaling
    Juan Sun et al, 2024, World J Gastroenterol CrossRef
  54. Epidermal Growth Factor Receptor Targeting in Colorectal Carcinoma: Antibodies and Patient-Derived Organoids as a Smart Model to Study Therapy Resistance
    Samuele Tardito et al, 2024, IJMS CrossRef
  55. Identification and validation of calcium extrusion-related genes prognostic signature in colon adenocarcinoma
    Mingpeng Jin et al, 2024 CrossRef
  56. Precision prognosis of colorectal cancer: a multi-tiered model integrating microsatellite instability genes and clinical parameters
    Yonghong Wang et al, 2024, Front. Oncol. CrossRef
  57. Dihydroartemisinin regulates the apoptosis and growth of colorectal cancer by suppressing DPYSL2 and increasing TF and ACHE
    Xiao Zhang et al, 2024, Food Bioscience CrossRef
  58. Inhibition of Angiogenesis and Metastasis in Colorectal Cancer Cell Lines through KRAS-Associated Signaling Pathways by 2-Methoxy-6-undecyl-1,4-benzoquinone.
    Noor Izzah Abd Rahman et al, 2024, Chemico-Biological Interactions CrossRef
  59. Cellular and molecular events in colorectal cancer: biological mechanisms, cell death pathways, drug resistance and signalling network interactions
    Lei Yan et al, 2024, Discov Onc CrossRef
  60. Association between Altered Oncogenic Signaling Pathways and Overall Survival of Patients with Metastatic Colorectal Cancer.
    Yi-Hsuan Huang et al, 2021, Diagnostics (Basel) CrossRef
  61. An Updated Review of Resistin and Colorectal Cancer
    Aliki Vaia Rompou et al, 2024 CrossRef
  62. Therapeutic Strategies and Potential Actions of Female Sex Steroid Hormones and Their Receptors in Colon Cancer Based on Preclinical Studies
    Amani A. Mahbub, 2022, Life CrossRef
  63. KLF7 enhances the invasion and migration of colorectal cancer cells via the miR-139-5p/TPD52 axis
    Juan Zhang et al, 2024, Cancer Biology & Therapy CrossRef
  64. Identifying key genes against rutin on human colorectal cancer cells via ROS pathway by integrated bioinformatic analysis and experimental validation
    Mansour K. Gatasheh, 2024, Computational Biology and Chemistry CrossRef
  65. A Benzimidazole-Based N-Heterocyclic Carbene Derivative Exhibits Potent Antiproliferative and Apoptotic Effects against Colorectal Cancer
    Sarah Al-Nasser et al, 2024, Medicina CrossRef
  66. Gut microbiota alterations in colorectal adenoma-carcinoma sequence based on 16S rRNA gene sequencing: a systematic review and meta-analysis
    Yi-jun Wu et al, 2024, Microbial Pathogenesis CrossRef
  67. Colorectal Carcinoma: Is There Any Correlation between Her2/neu Expression, Ki-67 Score, and Tumor Budding and Clinicopathological Parameters?—A Prospective Institution-Based Study
    Susnata Khan et al, 2024, South Asian J Cancer CrossRef
  68. Mindfulness intervention, homogeneous medical concept, and concentrated solution nursing for colorectal cancer patients: a retrospective study
    Yaning Feng et al, 2024, BMC Cancer CrossRef
  69. Alkaloid-Based Modulators of the PI3K/Akt/mTOR Pathway for Cancer Therapy: Understandings from Pharmacological Point of View
    Fatima Mokhfi et al, 2024, Chemico-Biological Interactions CrossRef
  70. From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies
    Ehsan Gharib et al, 2024, IJMS CrossRef
  71. LINC01094: A Key Long Non-Coding RNA in the Regulation of Cancer Progression and Therapeutic Targets
    Qiang Yi et al, 2024, Heliyon CrossRef
  72. Netrin-1-CD146 and netrin-1-S100A9 are associated with early stage of lymph node metastasis in colorectal cancer
    Jin-Ming Chen et al, 2024, BMC Gastroenterol CrossRef
  73. Frequency of KRAS and BRAF mutations in colorectal carcinoma and their association with clinical-pathological characteristics in a tertiary hospital in Kenya
    Samuel Gakinya et al, 2024, Front. Med. CrossRef
  74. Advances in Chitosan-Based Smart Hydrogels for Colorectal Cancer Treatment
    Urszula Piotrowska et al, 2024, Pharmaceuticals CrossRef
  75. Mechanism of Guishao Yigong decoction in treating colorectal cancer based on network pharmacology and experimental validation
    Yuwen Fan et al, 2024 CrossRef
  76. An updated landscape on nanopharmaceutical delivery for mitigation of colon cancer
    Maria Shahzad et al, 2024, Naunyn-Schmiedeberg's Arch Pharmacol CrossRef
  77. Identification and Verification of Key Genes in Colorectal Cancer Liver Metastases Through Analysis of Single-Cell Sequencing Data and TCGA Data
    Hui Zhang et al, 2024, Ann Surg Oncol CrossRef
  78. Establishment and Clinical Significance of the Patient-Derived Xenograft Model of Colorectal Cancer
    Li Zhang et al, 2024 CrossRef
  79. The progress and challenges in modeling colorectal cancer and the impact on novel drug discovery
    Natália Teixeira et al, 2024, Expert Opinion on Drug Discovery CrossRef
  80. Unraveling the complexities of colorectal cancer and its promising therapies – An updated review
    Sayan Saha et al, 2024, International Immunopharmacology CrossRef
  81. Identification of key lncRNAs associated with oxaliplatin resistance in colorectal cancer cells and isolated exosomes: From In-Silico prediction to In-Vitro validation
    Roxana Sahebnasagh et al, 2024, PLoS ONE CrossRef
  82. null
    Florencia Adriana Lohmann et al, 2025 CrossRef
  83. Association between the expression level of miRNA‑374a and TGF‑β1 in patients with colorectal cancer
    Noha El Din et al, 2024, World Acad Sci J CrossRef
  84. ASO Author Reflections: Why are the Identification and Verification of Key Genes in Colorectal Cancer Liver Metastases so Important?
    Hui Zhang et al, 2024, Ann Surg Oncol CrossRef
  85. Innovative strategies to optimise colorectal cancer immunotherapy through molecular mechanism insights
    Quanjun Lin et al, 2024, Front. Immunol. CrossRef
  86. LncRNA CRNDE and HOTAIR; Molecules Behind the Scenes in the Progression of Gastrointestinal Cancers through Regulating microRNAs
    Mohamed J. Saadh et al, 2024, Pathology - Research and Practice CrossRef
  87. Network pharmacology and anticancer mechanism study of Dendrobium nobile dendrobine in the treatment of colorectal cancer
    Pei Luo et al, 2024, Discov Onc CrossRef
  88. null
    Srijit Das et al, 2024 CrossRef
  89. Acute exposure to nitrogen mustard induces rapid nuclear component regulation and delayed stress to exogenous stimuli
    Jin Cheng et al, 2025, International Immunopharmacology CrossRef
  90. Impact of adjuvant chemotherapy on survival after pathological complete response in rectal cancer: a meta-analysis of 31,558 patients
    Francisco Cezar Aquino de Moraes et al, 2024, Int J Colorectal Dis CrossRef
  91. Computer-guided identification of novel inhibitors of apoptosis-signaling kinase 1 from Spondia mombim bioactive compounds against colorectal cancer
    Olusola Olalekan Elekofehinti et al, 2025, Egypt J Med Hum Genet CrossRef
  92. hnRNPA2B1 drives colorectal cancer progression via the circCDYL/EIF4A3/PHF8 axis
    Yu‐Kai Sun et al, 2025, The Kaohsiung J of Med Scie CrossRef
  93. Wnt Pathway-Targeted Therapy in Gastrointestinal Cancers: Integrating Benchside Insights with Bedside Applications
    Anirudh Nayak et al, 2025, Cells CrossRef
  94. GRP78: A New Promising Candidate in Colorectal Cancer Pathogenesis and Therapy
    Wang Song et al, 2025, European Journal of Pharmacology CrossRef